<strong>The Neuroprotective Effect of Estrogen is Associated with Regulation Energy Metabolism</strong>

Abstract

Abstract:

Estrogen has been demonstrated to be involved in the development and progress of Alzheimer's disease. Numerous studies show the neuroprotective effects of estrogen, but the underlying mechanism remains unclear. Here, we discussed the neuroprotective effects of estrogen, particularly focusing on the energy metabolism related to improvement of glucose metabolism, regulation of the brain metabolism and enhancement of mitochondrial function. Application of estrogen or estrogen substitutes to maintain the nervous system function and to prevent and control Alzheimer's disease could be a fruitful field in future studies.

Key words:estrogen,Alzheimer's disease (AD),mitochondrial,energy metabolism

CLC Number:

R964

SHEN Li-xia, ZHANG Dan-shen.The Neuroprotective Effect of Estrogen is Associated with Regulation Energy Metabolism[J]. ACTA NEUROPHARMACOLOGICA, 2012, 2(1): 28-32.

References

[1] Rudy J Castellani, Raj K Rolston, Mark A Smith. Alzheimer’s disease [J]. Dis Mon, 2010, 56(9):484–546.

[2] Victor W. Henderson. Aging, estrogens, and episodic memory in women [J]. Cogn Behav Neurol, 2009, 22(4): 205–214.

[3] Barbara B Sherwin. Estrogen and cognitive aging in women [J]. Trends Pharmacol Sci, 2002, 23(11):527–534.

[4] Robert D Brinton. Impact of estrogen therapy on Alzheimer’s disease: a fork in the road? [J]. CNS Drugs, 2004, 18(7):405–422.

[5] Christian J Pike, Jenna C Carroll, Emily R Rosario, et al. Protective actions of sex steroid hormones in Alzheimer’s disease [J]. Front Neuroendocrinol, 2009, 30(2): 239–258

[6] Tonita E Wroolie, Heather A Kenna, Katherine E Williams, et al. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens [J]. Am J Geriatr Psychiatry, 2011, 19(9): 792–802.

[7] Xu Jinping, Monina Bartoces, Anne Victoria Neale, et al. Natural history of menopause symptoms in primary care patients: a metro net study [J].J Am Board Fam Pract, 2005, 18(5):374–382.

[8] Oliver Kretz, Lars Fester, Uwe Wehrenberg, et al. Hippocampal synapses depend on hippocampal estrogen synthesis [J].J Neurosci, 2004, 24(26):5913–5921.

[9] Yasushi Hojo, Gen Murakami, Hideo Mukai, et al. Estrogen synthesis in the brain-role in synaptic plasticity andmemory[J]. Mol Cell Endocrinol, 2008, 290(1-2):31–43.

[10] Teresa A Milner, Kehinde Ayoola, Carrie T Drake, et al. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation[J]. J Comp Neurol, 2005, 491(2):81–95.

[11] Shughrue PJ, Scrimo PJ, Merchenthaler I. Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain[J]. Neuroscience, 2000, 96(1):41–49.

[12] Dean P Edwards. Regulation of signal transduction pathways by estrogen and progesterone [J]. Annu Rev Physiol, 2005, 67:335–376.

[13] Giovanni Pagano, Giuseppe Castello. Oxidative stress and mitochondrial dysfunction in down syndrome [J]. Adv Exp Med Biol, 2012, 724:291-299.

[14] 周晓雯,苏朝芬,罗焕敏.线粒体与神经退行性疾病[J].神经药理学报, 2011, 1（3）:41-46

[15] Verri M, Pastoris O, Dossena M, et al. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer’s disease[J]. Int J Immunopathol Pharmacol, 2012, 25(2):345-353.

[16] Paula I Moreira, Maria S Santos, Raquel Seica, et al. Brain mitochondrial dysfunction as a link between Alzheimer’s diseaseand diabetes[J]. J Neurol Sci, 2007, 257(1-2):206–214.

[17] Jiong Shi, James W Simpkins. 17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier [J]. Am J Physiol, 1997, 272 (6 Pt 1):E1016-1022.

[18] Clara M Cheng, Matt Cohen, Jie Wang, et al. Estrogen augments glucose transporter and IGF1expression in primate cerebral cortex[J]. Faseb J, 2001,15(6):907–915.

[19] Simpkins JW, Wang J, Wang X, et al. Mitochondria play a central role in estrogen-induced neuroprotection[J]. Curr Drug Targets CNS Neurol Disord, 2005, 4(1):69–83.

[20] Jon Nilsen, Chen Shuhua, Ronald W Irwin, et al. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function[J]. BMC Neurosci, 2006, 7(3):74-88.

[21] James W Simpkins, Yi Kun-don, Yang Shao-hua, et al. Mitochondrial mechanisms of estrogen neuroprotection[J].Biochim Biophys Acta, 2010, 1800(10):1113-1120

[22] Kostanyan A, Nazaryan K. Rat brain glycolysis regulation by estradiol-17beta [J]. Biochim Biophys Acta, 1992, 1133(3):301–306.

[23] Clara M Cheng, Matt Cohen, Jie Wang, et al. Estrogen augments glucose transporter and IGF-1expression in primate cerebral cortex[J]. Faseb J, 2001, 15(6):907–915.

[24] Pablo Mendez, Francisco Wandosell, Luis M Garcia-Segura. Cross-talk between estrogen receptors and insulinlike growth factor-I receptor in the brain: cellular and molecular mechanisms [J]. Front Neuroendocrinol, 2006, 27(4):391–403.

[25] Pablo Mendez, Luis Miguel Garcia-Segura. Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells [J]. Endocrinology, 2006, 147(6):3027–3039.

[26] Gloria P Cardona-Gomez, Pablo Mendez, Lydia L Don Carlos, et al. Interactions of estrogen and insulin-like growth factor-I in the brain: molecular mechanisms and functional implications[J]. J Steroid Biochem Mol Biol, 2002, 83(1-5):211–217.

[27] Luis Miguel Garcia-Segura, Gloria Patrica Cardona-Gomez, Julie Ann Chowen, et al. Insulin-like growth factor-Ireceptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection [J]. J Neurocytol, 2000, 29(5-6):425–437.

[28] Carro E, Trejo JL, Gomez-Isla T, et al. Serum insulin-like growth factor Iregulates brain amyloid-beta levels[J]. Nat Med, 2002, 8(12):1390–1397.

[29] Pauline M Maki, Susan M Resnick. Longitudinal effects of estrogen replacement therapy on PET cerebralblood flow and cognition [J]. Neurobiol Aging, 2000, 21(2):373–383.

[30] Natalie L Rasgon, Daniel Silverman, Prabha Siddarth, et al. Estrogen use and brain metabolic change in postmenopausal women[J].Neurobiol Aging, 2005, 26(2):229–235.

[31] Winnie S Liang, Eric M Reiman, Jon Valla, et al. Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons[J]. Proc Natl Acad Sci USA, 2008, 105(11):4441–4446.

[32] 孙爱华,姜颖, 贺福初.线粒体蛋白质表达谱的研究进展[J].遗传, 2006, 28(10): 1311-1315,

[33] Jon Nilsen, Ronald W Irwin, Timothy K Gallaher, et al. Estradiol in vivo regulation of brain mitochondrial proteome[J]. J Neurosci, 2007, 27(51):14069–14077.

[34] Roberta D Brinton, Chen Shu-hua, Marissa Montoya, et al. The women’s health initiative estrogen replacement therapy is neurotrophic and neuroprotective[J]. Neurobiol Aging, 2000, 21(3):475–496.

[35] Lina Holmquist, Grant Stuchbury, Katrin Berbaum, et al. Lipoic acid as a novel treatment for Alzheimer’s disease and related dementias[J]. Pharmacol Ther, 2007, 113(1):154–164.

[36] Chris Stirone, Sue P Duckles, Diana N Krause, et al. Estrogen increases mitochondrial efficiency andreduces oxidative stress in cerebral blood vessels[J]. Mol Pharmacol, 2005, 68(4):959–965.

[37] Michael T. Lin, M.Flint Beal. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases [J].Nature, 2006, 443(7113):787–795.

[38] Parvesh Bubber, Vahram Haroutunian, Gene Fisch, et al. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications [J]. Ann Neurol, 2005, 57(5):695–703.

[39] Eric A Sribnick, Angelo M Del Re, Swapan K Ray, et al. Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels[J]. Brain Res, 2009, 18(1276):159-170.

[40] Jon Nilsen, Roberta Diaz Brinton. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression[J]. Proc Natl Acad Sci USA, 2003, 100(5):2842–2847.

[41] Nilsen J, Brinton RD. Mitochondria as therapeutic targets of estrogen action in the central nervous system [J]. Curr Drug Targets CNS Neurol Disord, 2004, 3(4):297–313.

[42] John H Morrison, Roberta D Brinton, Peter J Schmidt, et al. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women [J]. J Neurosci, 2006, 26(41):10332–10348

The Neuroprotective Effect of Estrogen is Associated with Regulation Energy Metabolism

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

[1]	ZHEN Yan-jie, GUO Tong-lin, ZHAO Yu-wei, SHEN Li-xia.Study Progress on Phytoestrogen-Mediated Mitochondrial Pathway’s Neuroprotective Effects in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 40-46.
[2]	YANG-Lin，AI-Jing.Research Progress of Brain-Derived Estrogen in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2019, 9(5): 50-64.
[3]	MIAO Ming-san，PENG Meng-fan，FANG Xiao-yan，JIA Jiao-jiao，BAI Ming.Effects of Sargentodoxacuneata Total Phenolic Acids on Oxidative Stress Level and Energy Metabolism of Brain Tissues in Rats with Cerebral Ischemia Reperfusion Injury[J]. Acta Neuropharmacologica, 2019, 9(1): 1-5.
[4]	YUE Zhong-bao, YOU Jia,LI Zhuo-ming,CHEN Shao-rui,LIU Pei-qing.SIRT3: A Potential Target for CHF?[J]. Acta Neuropharmacologica, 2018, 8(5): 80-81.
[5]	SHEN li-xia1，LIU Liang-liang1，ZHANG Ming1，LIU Yang1，ZHANG Dan-shen 2*.Research of Quercetin’s Estrogen-Like Action on Central Nervous System and Its Mechanisms[J]. Acta Neuropharmacologica, 2018, 8(4): 23-25.
[6]	ZHONG Jia-hong, WANG Hai-tao, XU Jiang-ping.Inhibition of Phosphodiesterase 4 by FCPR16 Protects SH-SY5Y Cells against MPP+-Induced Cell Death through Activating cAMP/PKA/CREB and Epac/Akt Signaling Pathways[J]. Acta Neuropharmacologica, 2018, 8(4): 54-55.
[7]	LI Jiang-man，WANG Yi-di，WANG Feng-ping，LI Wei.Research Progress of Cerebral Ischemia Reperfusion Injury and Its Mechanisms Related to Astrocytes[J]. Acta Neuropharmacologica, 2017, 7(6): 50-59.
[8]	WANG Cui, GUO Tong-lin, SHEN Li-xia.Study on the Neuroprotective Effects of Phytoestrogens in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2017, 7(4): 43-52.
[9]	ZHANG Li-na，ZHANG Xin，XUE Juan，ZHANG Dan-shen.Advances Achievements of Traditional Chinese Medicine on the Signaling Pathways in Central Nervous Degenerative Diseases[J]. Acta Neuropharmacologica, 2017, 7(3): 33-42.
[10]	LIU Yang, SHEN Li-Xia.Research Progress of Estrogen Signal Pathway in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2015, 5(4): 43-54.
[11]	ZHONG Ming, SHEN Li-Xia.Study of the Mechanism of Estrogen on Neuroprotective Effect[J]. Acta Neuropharmacologica, 2015, 5(2): 54-64.
[12]	LIU Liang-jing, SHEN Li-xia.An Update on Neuroprotective Effects of Estrogen in Alzheimer's Disease[J]. Acta Neuropharmacologica, 2013, 3(4): 58-64.
[13]	LI Zeng-fang,HE Xiao-li,BI Ming-gang.Effects of Tamoxifen on Learning and Memory in Female Rats[J]. Acta Neuropharmacologica, 2013, 3(3): 1-7.
[14]	MA Xin-zhe,LV Yang，WANG Hai-ping.A Review on the Relationship between Estrogen, Estrogen Receptor and Hypertension Disease[J]. Acta Neuropharmacologica, 2013, 3(3): 34-38.
[15]	SHEN Li-xia, ZHANG Li.Progresson the Neuroprotective Effects of Estrogen[J]. Acta Neuropharmacologica, 2012, 2(3): 29-36.